Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for Post-CPB Vasoplegic Syndrome
NCT04668859Phase 4Terminated
- Sponsor
- MedStar Health Research Institute
- Start
- Jul 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in vasoplegic syndrome (VPS) comparing Midodrine Arm with Placebo Arm (2 arms). Primary endpoint: Time from procedure end until discontinuation of IV vasopressors at 12 months. Started Jul 2016; status: terminated.
02
Drugs
midodrine
03
Conditions
vasoplegic syndrome (VPS)
Beyond the preview
Go deeper on NCT04668859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04668859.